COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,617 Articles (22,913 medRxiv, 8,704 bioRxiv)

Most recent first Previous |  Page 1381: Articles 13801-13810  | Next

The impact of large mobile air purifiers on aerosol concentration in classrooms and the reduction of airborne transmission of SARS-CoV-2
Duill, F. F., Schulz, F., Jain, A., Krieger, L., van Wachem, B., Beyrau, F.
10.1101/2021.07.23.21261041 — Posted: 2021-07-26
Early multidrug treatment of SARS-CoV-2 (COVID-19) and decreased case fatality rates in Honduras
Ontai, S. C., Valerio Pascua, F., Zeng, L., Sierra Hoffman, M., VanBuren, V., McCullough, P. A.
10.1101/2021.07.21.21260223 — Posted: 2021-07-25
Safety and Immunogenicity of Nanocovax, a SARS-CoV-2 Recombinant Spike Protein Vaccine
Nguyen, T. P., Do, Q., Lan, L. T., Dinh, D. V., Khong, H., Do, S. M.
10.1101/2021.07.22.21260942 — Posted: 2021-07-25 Discussion: Onsite
Use of Indomethacin for mild and moderate Covid -19 patients. A Randomized Control Trial
rajan, r., Surapaneni, K. M., Sukumaran, S. K., Kamaraj, D., Devisuga, S. S., Ravi, S. O., Vijayaraghavalu, S., Ramarathnam, K. K.
10.1101/2021.07.24.21261007 — Posted: 2021-07-25 Discussion: Onsite | Offsite
Proxalutamide Improves Inflammatory, Immunologic, and Thrombogenic Markers in Mild-to-Moderate COVID-19 Males and Females: an Exploratory Analysis of a Randomized, Double-Blinded, Placebo-Controlled Trial Early Antiandrogen Therapy (EAT) with Proxalutamide (The EAT-Proxa Biochemical AndroCoV-Trial)
Cadegiani, F. A., Goren, A., Wambier, C. G., Zimerman, R.
10.1101/2021.07.24.21261047 — Posted: 2021-07-25
A cluster randomised trial of the impact of a policy of daily testing for contacts of COVID-19 cases on attendance and COVID-19 transmission in English secondary schools and colleges
Young, B. C., Eyre, D. W., Kendrick, S., White, C., Smith, S., Beveridge, G., Nonnenmacher, T., Ichofu, F., Hillier, J., Diamond, I., Rourke, E., Dawe, F., Day, I., Davies, L., Staite, P., Lacey, A., McCrae, J., Jones, F., Kelly, J., Bankiewicz, U., Tunkel, S., Ovens, R., Chapman, D., Marks, P., Hicks, N., Fowler, T., Hopkins, S., Yardley, L., Peto, T. E.
10.1101/2021.07.23.21260992 — Posted: 2021-07-25
A cross-sectional study of socioeconomic status and sickness presenteeism in Japanese workers during the COVID-19 pandemic
Masuda, M., Ishimaru, T., Hino, A., Ando, H., Tateishi, S., Nagata, T., Tsuji, M., Matsuda, S., Fujino, Y.
10.1101/2021.07.23.21260909 — Posted: 2021-07-25
A Multi-Site Analysis of the Prevalence of Food Security in the United States, before and during the COVID-19 Pandemic
Niles, M. T., Beavers, A. W., Clay, L. A., Dougan, M. M., Pignotti, G. A., Rogus, S., Savoie-Roskos, M. R., Schattman, R. E., Zack, R. M., Acciai, F., Allegro, D., Belarmino, E. H., Bertmann, F., Biehl, E., Birk, N., Bishop-Royse, J., Bozlak, C., Bradley, B., Brenton, B. P., Buszkiewicz, J., Cavaliere, B. N., Cho, Y., Clark, E. M., Coakley, K., Coffin-Schmitt, J., Collier, S. M., Coombs, C., Dressel, A., Drewnowski, A., Evans, T., Feingold, B. J., Fiechtner, L., Fiorella, K. J., Funderburk, K., Gadhoke, P., Gonzales-Pacheco, D., Greiner Safi, A., Gu, S., Hanson, K. L., Harley, A., Harper, K., Hosler, A. S., Ismach, A., Josephson, A., Laestadius, L., LeBlanc, H., Lewis, L. R., Litton, M. M., Martin, K. S., Martin, S., Martinelli, S., Mazzeo, J., Merrill, S. C., Neff, R., Nguyen, E., Ohri-Vachaspati, P., Orbe, A., Otten, J. J., Parmer, S., Pemberton, S., Qusair, Z. A. A., Rivkina, V., Robinson, J., Rose, C. M., Sadeghzadeh, S., Sivaramakrishnan, B., Torres Arroyo, M., Voorhees, M., Yerxa, K.
10.1101/2021.07.23.21260280 — Posted: 2021-07-25
Shocked-relaxed-tired: Mental health during the three waves of the Covid-19
Novotny, J. S., Gonzalez Rivas, J. P., Kunzova, S., Skladana, M., Pospisilova, A., Polcrova, A., Vassilaki, M., Medina Inojosa, J. R., Lopez-Jimenez, F., Geda, Y. E., Stokin, G. B.
10.1101/2021.07.25.21261094 — Posted: 2021-07-25
Antiviral metabolite 3'-Deoxy-3',4'-didehydro-cytidine is detectable in serum and identifies acute viral infections including COVID-19
Mehta, R., Chekmeneva, E., Jackson, H., Sands, C., Mills, E., Arancon, D., Li, H. K., Arkell, P., Rawson, T. M., Hammond, R., Amran, M., Haber, A., Cooke, G., Noursadeghi, M., Kaforou, M., Lewis, M., Takats, Z., Sriskandan, S.
10.1101/2021.07.23.21260740 — Posted: 2021-07-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).